1. Home
  2. ANTX vs MRLN Comparison

ANTX vs MRLN Comparison

Compare ANTX & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.68

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Logo Merlin Inc. Common Stock

MRLN

Merlin Inc. Common Stock

HOLD

Current Price

$1.12

Market Cap

172.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANTX
MRLN
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
172.8M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
ANTX
MRLN
Price
$3.68
$1.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
★ $9.00
$7.92
AVG Volume (30 Days)
302.0K
★ 3.6M
Earning Date
11-11-2026
11-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 32.56
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.23
Revenue Next Year
N/A
$153.29
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$1.15
52 Week High
$7.19
$17.00

Technical Indicators

Market Signals
Indicator
ANTX
MRLN
Relative Strength Index (RSI) 25.88 23.91
Support Level $2.87 N/A
Resistance Level $5.21 $3.45
Average True Range (ATR) 0.43 0.15
MACD -0.16 0.00
Stochastic Oscillator 13.16 0.00

Price Performance

Historical Comparison
ANTX
MRLN

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

About MRLN Merlin Inc. Common Stock

Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.

Share on Social Networks: